ZA914296B - Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical use - Google Patents
Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical useInfo
- Publication number
- ZA914296B ZA914296B ZA914296A ZA914296A ZA914296B ZA 914296 B ZA914296 B ZA 914296B ZA 914296 A ZA914296 A ZA 914296A ZA 914296 A ZA914296 A ZA 914296A ZA 914296 B ZA914296 B ZA 914296B
- Authority
- ZA
- South Africa
- Prior art keywords
- dialkoxy
- pyridinyl
- preparation
- pharmaceutical use
- benzimidazole derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9002206A SE9002206D0 (sv) | 1990-06-20 | 1990-06-20 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA914296B true ZA914296B (en) | 1992-03-25 |
Family
ID=20379831
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA914296A ZA914296B (en) | 1990-06-20 | 1991-06-05 | Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical use |
ZA914297A ZA914297B (en) | 1990-06-20 | 1991-06-05 | Substituted benzimidazoles,process for their preparation and their pharmaceutical use |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA914297A ZA914297B (en) | 1990-06-20 | 1991-06-05 | Substituted benzimidazoles,process for their preparation and their pharmaceutical use |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP0535081A1 (xx) |
JP (1) | JPH05507713A (xx) |
CN (1) | CN1058212A (xx) |
AP (1) | AP215A (xx) |
AU (1) | AU649453B2 (xx) |
BG (1) | BG97200A (xx) |
CA (1) | CA2083714A1 (xx) |
CZ (1) | CZ279772B6 (xx) |
FI (1) | FI925766A0 (xx) |
HU (1) | HUT62881A (xx) |
IE (1) | IE912025A1 (xx) |
IL (1) | IL98470A0 (xx) |
IS (1) | IS3721A7 (xx) |
LT (2) | LT3977B (xx) |
LV (1) | LV10953A (xx) |
MA (1) | MA22199A1 (xx) |
NO (1) | NO924775L (xx) |
NZ (1) | NZ238546A (xx) |
OA (1) | OA09682A (xx) |
PT (1) | PT98035A (xx) |
RO (1) | RO110493B1 (xx) |
SE (1) | SE9002206D0 (xx) |
TN (1) | TNSN91049A1 (xx) |
TW (1) | TW216418B (xx) |
WO (1) | WO1991019711A1 (xx) |
YU (1) | YU104191A (xx) |
ZA (2) | ZA914296B (xx) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9002043D0 (sv) * | 1990-06-07 | 1990-06-07 | Astra Ab | Improved method for synthesis |
SE9103776D0 (sv) * | 1991-12-19 | 1991-12-19 | Astra Ab | New compounds |
IS4232A (is) * | 1993-12-06 | 1995-06-07 | Astra Aktiebolag | Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun |
SE9500422D0 (sv) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
SE9500478D0 (sv) * | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
SE9600070D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
DE60015607T2 (de) | 2000-02-24 | 2005-11-10 | Kopran Research Laboratories Ltd. | Oral verabreichbare säurebeständige geschwürbehandelnde benzimidazolderivate |
SE0101379D0 (sv) | 2001-04-18 | 2001-04-18 | Diabact Ab | Komposition som hämmar utsöndring av magsyra |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
ATE419840T1 (de) | 2002-04-09 | 2009-01-15 | Flamel Tech Sa | Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen |
SE0203065D0 (sv) | 2002-10-16 | 2002-10-16 | Diabact Ab | Gastric acid secretion inhibiting composition |
EP1708684A2 (en) | 2003-09-26 | 2006-10-11 | Alza Corporation | Drug coating providing high drug loading and methods for providing the same |
TW200606163A (en) | 2004-04-22 | 2006-02-16 | Eisai Co Ltd | Imidazopyridine compound |
US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
US20070015782A1 (en) | 2005-04-15 | 2007-01-18 | Eisai Co., Ltd. | Benzimidazole compound |
US9040564B2 (en) | 2005-04-28 | 2015-05-26 | Eisai R&D Management Co., Ltd. | Stabilized composition |
US7803817B2 (en) | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
US7981908B2 (en) | 2005-05-11 | 2011-07-19 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
WO2007122686A1 (ja) * | 2006-04-14 | 2007-11-01 | Eisai R & D Management Co., Ltd. | ベンズイミダゾール化合物 |
ES2511792T3 (es) | 2006-07-25 | 2014-10-23 | Vecta Ltd. | Composiciones y métodos para la inhibición de la secreción de ácido gástrico usando derivados de pequeños ácidos dicarboxílicos en combinación con IBP |
WO2008047681A1 (fr) * | 2006-10-13 | 2008-04-24 | Eisai R & D Management Co., Ltd. | Benzimidazole présentant une activité inhibitrice de la sécrétion d'acide gastrique |
EA201100313A1 (ru) | 2008-09-09 | 2011-10-31 | Астразенека Аб | Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом |
EP2445499A4 (en) | 2009-06-25 | 2013-02-27 | Astrazeneca Ab | METHOD FOR TREATING A PATIENT WITH RISK OF DEVELOPING A NSAID-ASSOCIATED SPURGE |
WO2011080500A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
WO2011080502A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
US20120294937A1 (en) | 2009-12-29 | 2012-11-22 | Novartis Ag | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
EP2601947A1 (en) | 2011-12-05 | 2013-06-12 | Abo Bakr Mohammed Ali Al-Mehdar | Fixed-dose combination for treatment of helicobacter pylori associated diseases |
WO2013101897A2 (en) | 2011-12-28 | 2013-07-04 | Pozen Inc. | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
KR102409502B1 (ko) * | 2016-09-14 | 2022-06-16 | 위펑 제인 쳉 | D-아미노산 옥시다제 (daao) 저해제로서 신규한 치환된 벤즈이미다졸 유도체 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE418966B (sv) | 1974-02-18 | 1981-07-06 | Haessle Ab | Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan |
SE416649B (sv) | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
IN148930B (xx) | 1977-09-19 | 1981-07-25 | Hoffmann La Roche | |
SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
US4359465A (en) | 1980-07-28 | 1982-11-16 | The Upjohn Company | Methods for treating gastrointestinal inflammation |
CH644116A5 (de) | 1980-08-21 | 1984-07-13 | Hoffmann La Roche | Imidazolderivate. |
SE8300736D0 (sv) | 1983-02-11 | 1983-02-11 | Haessle Ab | Novel pharmacologically active compounds |
SE8301182D0 (sv) | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
IL75400A (en) * | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
AU568441B2 (en) * | 1984-09-24 | 1987-12-24 | Upjohn Company, The | 2-(pyridylalkenesulfinyl) benzimidazole derivatives |
IL76839A (en) * | 1984-10-31 | 1988-08-31 | Byk Gulden Lomberg Chem Fab | Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
US4738975A (en) | 1985-07-02 | 1988-04-19 | Takeda Chemical Industries, Ltd. | Pyridine derivatives, and use as anti-ulcer agents |
SE8505112D0 (sv) * | 1985-10-29 | 1985-10-29 | Haessle Ab | Novel pharmacological compounds |
NZ234564A (en) | 1986-11-21 | 1991-04-26 | Haessle Ab | 1-substituted benzimidazoles and pharmaceutical compositions |
DE3722810A1 (de) * | 1987-07-10 | 1989-01-19 | Hoechst Ag | Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung |
AU2621888A (en) * | 1987-10-30 | 1989-05-23 | Aktiebolaget Hassle | Omeprazole for treatment of diseases related to bone loss |
WO1989005299A1 (en) * | 1987-12-11 | 1989-06-15 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Novel benzimidazole derivatives |
EP0415990A1 (de) * | 1988-05-25 | 1991-03-13 | Byk Gulden Lomberg Chemische Fabrik GmbH | Neue fluoralkoxyverbindungen |
-
1990
- 1990-06-20 SE SE9002206A patent/SE9002206D0/xx unknown
-
1991
- 1991-06-05 ZA ZA914296A patent/ZA914296B/xx unknown
- 1991-06-05 ZA ZA914297A patent/ZA914297B/xx unknown
- 1991-06-11 AU AU80097/91A patent/AU649453B2/en not_active Ceased
- 1991-06-11 EP EP91911659A patent/EP0535081A1/en not_active Withdrawn
- 1991-06-11 RO RO92-01581A patent/RO110493B1/ro unknown
- 1991-06-11 WO PCT/SE1991/000415 patent/WO1991019711A1/en not_active Application Discontinuation
- 1991-06-11 JP JP91511435A patent/JPH05507713A/ja active Pending
- 1991-06-11 CA CA002083714A patent/CA2083714A1/en not_active Abandoned
- 1991-06-11 HU HU924033A patent/HUT62881A/hu unknown
- 1991-06-12 YU YU104191A patent/YU104191A/sh unknown
- 1991-06-12 IL IL98470A patent/IL98470A0/xx unknown
- 1991-06-12 TW TW080104582A patent/TW216418B/zh active
- 1991-06-14 NZ NZ238546A patent/NZ238546A/en unknown
- 1991-06-14 IE IE202591A patent/IE912025A1/en unknown
- 1991-06-18 MA MA22462A patent/MA22199A1/fr unknown
- 1991-06-19 PT PT98035A patent/PT98035A/pt not_active Application Discontinuation
- 1991-06-19 AP APAP/P/1991/000285A patent/AP215A/en active
- 1991-06-19 TN TNTNSN91049A patent/TNSN91049A1/fr unknown
- 1991-06-20 CN CN91105024A patent/CN1058212A/zh active Pending
- 1991-06-20 CZ CS911894A patent/CZ279772B6/cs unknown
- 1991-06-20 IS IS3721A patent/IS3721A7/is unknown
-
1992
- 1992-11-27 OA OA60306A patent/OA09682A/en unknown
- 1992-12-10 NO NO92924775A patent/NO924775L/no unknown
- 1992-12-18 FI FI925766A patent/FI925766A0/fi not_active Application Discontinuation
- 1992-12-18 BG BG097200A patent/BG97200A/bg unknown
-
1993
- 1993-08-27 LV LV931045A patent/LV10953A/xx unknown
- 1993-12-30 LT LTIP1713A patent/LT3977B/lt not_active IP Right Cessation
- 1993-12-30 LT LTIP1712A patent/LT3952B/lt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1991019711A1 (en) | 1991-12-26 |
MA22199A1 (fr) | 1992-04-01 |
ZA914297B (en) | 1992-03-25 |
NO924775D0 (no) | 1992-12-10 |
LT3977B (en) | 1996-06-25 |
AP215A (en) | 1992-09-02 |
OA09682A (en) | 1993-05-15 |
HU9204033D0 (en) | 1993-03-29 |
IS3721A7 (is) | 1991-12-21 |
AU8009791A (en) | 1992-01-07 |
CS189491A3 (en) | 1992-04-15 |
CN1058212A (zh) | 1992-01-29 |
RO110493B1 (ro) | 1996-01-30 |
NO924775L (no) | 1992-12-10 |
FI925766A (fi) | 1992-12-18 |
SE9002206D0 (sv) | 1990-06-20 |
YU104191A (sh) | 1994-01-20 |
PT98035A (pt) | 1992-03-31 |
TNSN91049A1 (fr) | 1992-10-25 |
CZ279772B6 (cs) | 1995-06-14 |
IL98470A0 (en) | 1992-07-15 |
TW216418B (xx) | 1993-11-21 |
LT3952B (en) | 1996-05-27 |
EP0535081A1 (en) | 1993-04-07 |
HUT62881A (en) | 1993-06-28 |
NZ238546A (en) | 1994-03-25 |
LV10953A (lv) | 1995-12-20 |
JPH05507713A (ja) | 1993-11-04 |
LTIP1712A (en) | 1995-08-25 |
AP9100285A0 (en) | 1991-07-31 |
AU649453B2 (en) | 1994-05-26 |
IE912025A1 (en) | 1992-01-01 |
FI925766A0 (fi) | 1992-12-18 |
LTIP1713A (en) | 1995-08-25 |
BG97200A (bg) | 1993-12-24 |
CA2083714A1 (en) | 1991-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL98472A0 (en) | Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical use | |
ZA914296B (en) | Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical use | |
ZA916583B (en) | 3-amidopyrazole derivatives,process for preparing these and pharmaceutical compositions containing them | |
EP0412848A3 (en) | Quinoline derivatives, process for their preparation and their use as medicaments | |
CS210291A3 (en) | Benzeneacetamide derivatives, process for their preparation and pharmaceuticals based on them | |
LTIP709A (en) | Sbstituted corticoid-17-alkylcarbonates, process for preparing thereof and pharmaceutical preparations | |
IL98864A0 (en) | Oxazolyl derivatives,process for their preparation and pharmaceutical compositions containing them | |
HU9202864D0 (en) | Gycinamide derivatives, their production and pharmaceutical preparatives containing them | |
EP0449026A3 (en) | Desoxynojirimycin derivatives, process for their preparation and their use in drugs | |
GB2240104B (en) | New arylvinylamide derivatives and process for their preparation | |
GB8917687D0 (en) | Aminopiperazine derivatives,processes for preparation thereof and pharmaceutical composition comprising the same | |
IL98812A0 (en) | Purine derivatives,process for their preparation and pharmaceutical compositions containing them | |
CS265391A3 (en) | Novel thienodiazepines, process for their preparation and pharmaceutical comprising them | |
IL97656A0 (en) | Purine derivatives,process for their preparation and pharmaceutical compositions comprising them | |
ZA925871B (en) | 3-deoxy-mannosamine derivatives and process for their preparation | |
LTIP760A (en) | Novel thienothiazine derivatives, process for preparing thereof and pharmaceutical preparations | |
HUT66140A (en) | New 2-spirocyclopropyl-cephalosporin-sulfone derivatives and process for the preparation thereof | |
IL97859A0 (en) | 1,5-benzothiazepinone derivatives,their preparation and pharmaceutical use | |
EP0488009A3 (en) | Piperidinoalkyl-benzoxazine-and-thiazine-compounds, processes for their preparation and drugs containing them | |
GB2234748B (en) | Quinoline derivatives, process for their preparation and their use as medicaments | |
EP0583698A3 (en) | Deoxy-cyclitol derivatives, process for their preparation and their use in medicaments. | |
EP0474590A3 (en) | Taurine derivatives, process for their preparation and their use | |
GB9119714D0 (en) | Trifluoromethylketone derivatives, process for preparation thereof and use thereof | |
IL88817A0 (en) | Phenoxypropanolamine derivatives,process for their preparation and pharmaceutical compositions comprising them | |
GB9116131D0 (en) | Fr901460 substance,process for preparation thereof and use thereof |